Publications by authors named "Kelly Furness"

Claim this Profile
D
Defining Target Engagement Required for Efficacy at the Retinoic Acid Receptor-Related Orphan Receptor C2 (RORγt).
Charles W Lugar, Christian A Clarke, Richard Morphy, Helene Rudyk, Selma Sapmaz, Kelly Furness

J Med Chem· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical Proteomic Characterization of a Covalent KRASG12C Inhibitor.
Aruna Wijeratne, Junpeng Xiao, Christopher Reutter, Kelly W Furness, Rebecca Leon

ACS Med Chem Lett· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The development of potent and selective bisarylmaleimide GSK3 inhibitors.
Thomas A Engler, Sushant Malhotra, Timothy P Burkholder, James R Henry, David Mendel, Kelly Furness

Bioorg Med Chem Lett· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted 3-imidazo[1,2-a]pyridin-3-yl- 4-(1,2,3,4-tetrahydro-[1,4]diazepino-[6,7,1-hi]indol-7-yl)pyrrole-2,5-diones as highly selective and potent inhibitors of glycogen synthase kinase-3.
Thomas A Engler, James R Henry, Sushant Malhotra, Brian Cunningham, Kelly Furness

J Med Chem· July 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthetic approaches to indolo[6,7-a]pyrrolo[3,4-c]carbazoles: potent cyclin D1/CDK4 inhibitors.
Margaret M Faul, Thomas A Engler, Kevin A Sullivan, John L Grutsch, Marcella T Clayton, Kelly Furness

J Org Chem· April 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Asymmetric Schmidt reaction of hydroxyalkyl azides with ketones.
Kiran Sahasrabudhe, Vijaya Gracias, Kelly Furness, Brenton T Smith, Christopher E Katz

J Am Chem Soc· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel, potent and selective cyclin D1/CDK4 inhibitors: indolo[6,7-a]pyrrolo[3,4-c]carbazoles.
Thomas A Engler, Kelly Furness, Sushant Malhotra, Concha Sanchez-Martinez, Chuan Shih

Bioorg Med Chem Lett· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis